Daiichi Sankyo

www.daiichisankyo.com

3-5-1 Nihonbashi Honcho
Chuo-ku
Tokyo
103-8426
Japan

+81 3 6225 1126

Activities

Packaging | Research & Development | Pharmaceutical

Related Companies

Related Content

ProLynx collaborates with Daiichi Sankyo on drug delivery
ProLynx collaborates with Daiichi Sankyo on drug delivery
Heptares Therapeutics enters agreement with Daichi Sankyo
Heptares Therapeutics enters agreement with Daichi Sankyo
Amgen and Daiichi Sankyo to commercialise biosimilars in Japan
Amgen and Daiichi Sankyo to commercialise biosimilars in Japan
Nitto Denko enters drug delivery partnership with Daiichi Sankyo
Nitto Denko enters drug delivery partnership with Daiichi Sankyo
Daiichi Sankyo appoints Antoine Yver as Global Head, Oncology Research and Development
Daiichi Sankyo appoints Antoine Yver as Global Head, Oncology Research and Development
Latest EU drug approvals span range of health issues
Latest EU drug approvals span range of health issues
Daiichi Sankyo closes its research unit in Germany
Daiichi Sankyo closes its research unit in Germany
Daiichi Sankyo to cut up to 1,200 jobs in the US
Daiichi Sankyo to cut up to 1,200 jobs in the US
Daiichi Sankyo to acquire US biotechnology company Ambit Biosciences
Daiichi Sankyo to acquire US biotechnology company Ambit Biosciences
Reimbursment issues hinder future development of personal therapies
Reimbursment issues hinder future development of personal therapies
Japan funds R&D for tropical medicines for poor countries
Japan funds R&D for tropical medicines for poor countries
Daiichi Sankyo, Virtici and Celdara Medical enter high potential therapeutics collaboration
Daiichi Sankyo, Virtici and Celdara Medical enter high potential therapeutics collaboration
Opioid-induced constipation – naloxegol
Opioid-induced constipation – naloxegol
Daiichi Sankyo makes two executive appointments
Daiichi Sankyo makes two executive appointments
Patent protection only guaranteed in EU if made after 1994
Patent protection only guaranteed in EU if made after 1994